Skip to main content
University of Wisconsin–Madison
Waisman Center
Waisman Center
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
  • Resources & Information Expand Collapse
    • Diagnoses (autism, cerebral palsy, Down syndrome) Hub Pages
    • Families
    • Employees
    • Providers
    • Researchers
    • Visitors
    • Students and Trainees
  • Clinical Services Expand Collapse
    • Clinics Overview
    • Autism Treatment Programs Overview
    • Community Ties
    • Community Ties Psychiatric Cinic
    • WIN: Wellness Inclusion Nursing
  • LEND / Training
  • IDDRC / Research Expand Collapse
    • IDDRC / Research Homepage
    • Principal Investigators
    • Laboratory Websites
    • Research Topics
    • Core Services
    • Scientific Cores Leadership
    • Affiliated Departments
    • Required Core Grant Acknowledgements
  • UCEDD Expand Collapse
    • UCEDD Home Page
    • Priority Areas
    • Programs
    • Products
    • Educational Opportunities
  • Participate in Research Expand Collapse
    • About Waisman Center Research
    • Enroll in a Registry
    • Studies Currently Recruiting
    • Contact
  • Core Services Expand Collapse
    • Overview
    • Administrative Core
    • Brain Imaging Core
    • Clinical Translational Core
    • IDD Models (Cellular and Molecular Neuroscience, hPSC Models, Rodent Models) Core
  • WECP
  • Biomanufacturing Expand Collapse
    • UW Researchers
    • External / Industry
  • COVID-19
  • About Us
  • News
  • Events
  • Give
  • Careers
  • People
  • Español
  1. Home
  2. Biomarkers

Biomarkers

Neuroimaging and biomarker evidence of neurodegeneration in asthma

MicroRNAs as Biomarkers of Charcot-Marie-Tooth Disease Type 1A

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer’s disease: a cross-sectional study

Physical activity and cognitive and imaging biomarkers of Alzheimer’s disease in down syndrome

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer’s disease in non-demented adults

ECMarker: interpretable machine learning model identifies gene expression biomarkers predicting clinical outcomes and reveals molecular mechanisms of human disease in early stages

Intellectual and Developmental Disabilities Research Centers: A Multidisciplinary Approach to Understand the Pathogenesis of Methyl-CpG Binding Protein 2-related Disorders

The Alzheimer’s Biomarker Consortium-Down Syndrome: Rationale and methodology

Cerebrospinal fluid biomarkers of Alzheimer’s disease in a cohort of adults with Down syndrome

Site footer content

University logo that links to main university website

Information For

  • Families
  • Visitors
  • Students and Trainees
  • Researchers
  • Employees
  • Providers
  • INTRANET

Stay Connected

  • Waisman Newsletter
  • Slide of the Week

Contact Us

  • 1500 Highland Ave
    Madison, WI 53705

    Business Office: 608.263.1656
    Clinics: 608.263.3301
    Director's Office: 608.263.5940
    Media Inquiries: 608.263.5837
  • Map map marker
  • Email: info@waisman.wisc.edu
  • Phone: 608.263.1656
    • facebook
    • twitter
    • youtube
    • instagram

Feedback, questions or accessibility issues: webmaster@waisman.wisc.edu.

This site was built using the UW Theme | Privacy Notice | © 2022 Board of Regents of the University of Wisconsin System.